Last $0.0002 USD
Change Today 0.00 / 0.00%
Volume 0.0
INOL On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 01/27/15 All times are local (Market data is delayed by at least 15 minutes).

inolife technologies inc (INOL) Snapshot

Open
$0.0002
Previous Close
$0.0002
Day High
$0.0002
Day Low
$0.0002
52 Week High
02/4/14 - $0.0050
52 Week Low
12/5/14 - $0.0001
Market Cap
113.5K
Average Volume 10 Days
200.2K
EPS TTM
--
Shares Outstanding
567.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for INOLIFE TECHNOLOGIES INC (INOL)

Related News

No related news articles were found.

inolife technologies inc (INOL) Related Businessweek News

No Related Businessweek News Found

inolife technologies inc (INOL) Details

Inolife Technologies, Inc., a development stage company, focuses on marketing healthcare products for individuals, physicians, hospitals, and outpatient facilities in the United States. Its products include DNA testing for Plavix; and pre-disposition screening for certain genetic diseases, and ancestry and paternity tests. The company is based in Raleigh, North Carolina.

6 Employees
Last Reported Date: 07/15/14

inolife technologies inc (INOL) Top Compensated Officers

Chairman, Chief Executive Officer, President ...
Total Annual Compensation: $310.0K
Compensation as of Fiscal Year 2014.

inolife technologies inc (INOL) Key Developments

Inolife Technologies, Inc. announced delayed 10-Q filing

On 11/14/2014, Inolife Technologies, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Inolife Technologies, Inc. Announces New Product Line Under the Brand of Kumi

InoLife Technologies, Inc. announced the roll out of a new line of products which will be under the brand name of Kumi. This line of products will be in the multi-billion dollar skin care and anti-aging industry. The products are produced and developed through a strategic alliance with pharmaceutical company and WHO GMP certified for all its products and is specialized in the manufacturing of Cephalosporins and its intermediates. It has a wide range of products and is fast expanding to meet the present and future market demands for the high value drugs. It manufactures the Active Pharmaceutical Ingredient (API) in bulk quantities for both Indian and international regulated and semi-regulated markets. All the drugs manufactured meet USP /BP /JP standards. InoLife will develop and offer a brand of products under the Kumi label. In the coming days INOL will launch and begin sales of their first product in the Kumi line.

Inolife Technologies, Inc. announced delayed 10-Q filing

On 08/14/2014, Inolife Technologies, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INOL:US $0.00 USD 0.00

INOL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for INOL.
View Industry Companies
 

Industry Analysis

INOL

Industry Average

Valuation INOL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INOLIFE TECHNOLOGIES INC, please visit www.inolifetech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.